Deborah Dunsire Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deborah Dunsire.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deborah Dunsire. Deborah Dunsire is Director in ALLERGAN INC ($AGN) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and President and CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and President, CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).
Latest Insider Trading Transactions of Deborah Dunsire
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, AGN, MLNM, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,550 | 0 | 10,425 | 7.9 K to 10.4 K (+32.38 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 941 | 0 | 12,134 | 11.2 K to 12.1 K (+8.41 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,468 | 0 | 11,193 | 7.7 K to 11.2 K (+44.89 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 7,875 | 4.9 K to 7.9 K (+61.54 %) |
| May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 740 | 0 | 7,725 | 7 K to 7.7 K (+10.59 %) |
| May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,726 | 0 | 6,985 | 4.3 K to 7 K (+64.01 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 4,875 | 1.9 K to 4.9 K (+160.00 %) |
| May 11 2018 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,174 | 0 | 4,259 | 2.1 K to 4.3 K (+104.27 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,085 | 0 | 2,085 | 0 to 2.1 K |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K |
| Apr 10 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.59 | 15,000 | 878,850 | 15,000 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | D | 113.55 | 5,355 | 608,060 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | D | 61.98 | 11,400 | 706,572 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | D | 46.66 | 11,400 | 531,924 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | D | 54.32 | 11,400 | 619,248 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | D | 60.60 | 11,400 | 690,840 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Option Exercise | M | 0.00 | 8,860 | 0 | 0 | |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Sell | D | 0.00 | 43,041 | 0 | 0 | 43 K to 0 (-100.00 %) |
| Mar 19 2015 | AGN | ALLERGAN INC | Dunsire Deborah | Director | Buy | M | 0.00 | 8,860 | 0 | 43,041 | 34.2 K to 43 K (+25.92 %) |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Option Exercise | D | 13.90 | 647,490 | 9,000,111 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Option Exercise | D | 10.84 | 100,000 | 1,084,000 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Option Exercise | D | 9.33 | 112,500 | 1,049,625 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Option Exercise | D | 9.99 | 112,500 | 1,123,875 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Option Exercise | D | 10.00 | 112,500 | 1,125,000 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Sell | D | 25.00 | 688,957 | 17,223,925 | 0 | 689 K to 0 (-100.00 %) |
| May 12 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President, CEO | Sell | U | 25.00 | 48,218 | 1,205,450 | 688,957 | 737.2 K to 689 K (-6.54 %) |
| Mar 11 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 13.34 | 14,096 | 188,036 | 806,074 | 820.2 K to 806.1 K (-1.72 %) |
| Mar 04 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 13.67 | 11,278 | 154,222 | 820,170 | 831.4 K to 820.2 K (-1.36 %) |
| Mar 04 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 13.67 | 12,542 | 171,438 | 831,448 | 844 K to 831.4 K (-1.49 %) |
| Feb 19 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | A | 13.90 | 647,490 | 9,000,111 | 647,490 | |
| Feb 19 2008 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 143,890 | 0 | 843,990 | 700.1 K to 844 K (+20.55 %) |
| Jul 20 2007 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 10.61 | 33,664 | 357,175 | 700,100 | 733.8 K to 700.1 K (-4.59 %) |
| Mar 12 2007 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 10.41 | 10,771 | 112,126 | 733,764 | 744.5 K to 733.8 K (-1.45 %) |
| Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | A | 10.84 | 100,000 | 1,084,000 | 100,000 | |
| Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 111,200 | 0 | 744,535 | 633.3 K to 744.5 K (+17.56 %) |
| Mar 01 2007 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 100,000 | 0 | 633,335 | 533.3 K to 633.3 K (+18.75 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | M | 9.33 | 37,500 | 349,875 | 112,500 | |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | M | 9.99 | 37,500 | 374,625 | 112,500 | |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | M | 10.00 | 37,500 | 375,000 | 112,500 | |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 11.51 | 100 | 1,151 | 533,335 | 533.4 K to 533.3 K (-0.02 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 11.52 | 5,200 | 59,904 | 533,435 | 538.6 K to 533.4 K (-0.97 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 11.53 | 3,900 | 44,967 | 538,635 | 542.5 K to 538.6 K (-0.72 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Sell | S | 11.50 | 103,300 | 1,187,950 | 542,535 | 645.8 K to 542.5 K (-15.99 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Buy | M | 9.33 | 37,500 | 349,875 | 645,835 | 608.3 K to 645.8 K (+6.16 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Buy | M | 9.99 | 37,500 | 374,625 | 608,335 | 570.8 K to 608.3 K (+6.57 %) |
| Oct 30 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Buy | M | 10.00 | 37,500 | 375,000 | 570,835 | 533.3 K to 570.8 K (+7.03 %) |
| Mar 08 2006 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 133,335 | 0 | 533,335 | 400 K to 533.3 K (+33.33 %) |
| Oct 03 2005 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | A | 9.33 | 150,000 | 1,399,500 | 150,000 | |
| Sep 01 2005 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | A | 9.99 | 150,000 | 1,498,500 | 150,000 | |
| Jul 20 2005 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Option Exercise | A | 10.00 | 150,000 | 1,500,000 | 150,000 | |
| Jul 20 2005 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 400,000 | 200 K to 400 K (+100.00 %) |
| Jul 20 2005 | MLNM | MILLENNIUM PHARMAC ... | Dunsire Deborah | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Page: 1